Digital Technology in Clinical Trials

Session Chair(s)

As our knowledge of disease manifestations and treatment approaches becomes more sophisticated, new opportunities exist to quantify important features of serious diseases for the first time.

There are now digital tools available to sponsors with the potential to create value in the drug development process beyond a specific product or disease state. These so-called platform technologies are tools that enable sponsors to better measure and interpret symptoms that impact many disease indications. Examples include symptoms such as fatigue, pain, cognition, speech, and autonomic measures.

This session will explore the value of adopting platform technologies to drug development programs and the path to regulatory acceptance of data generated by these novel tools.

Learning Objective :

At the conclusion of this session, participants should be able to:

• Identify case study examples of platform digital technologies tools in drug development programs.
• Propose benefits of data generated by these tools for patients, caregivers, HCPs, regulators, and payers
• Evaluate models for cooperative development and adoption of platform digital technologies in the biopharma ecosystem

Speaker(s)